Natural history of patients with congestive heart failure: Potential role of converting enzyme inhibitors in improving survival
dc.contributor.author | Pitt, Bertram | en_US |
dc.date.accessioned | 2006-04-07T19:25:10Z | |
dc.date.available | 2006-04-07T19:25:10Z | |
dc.date.issued | 1986-10-31 | en_US |
dc.identifier.citation | Pitt, Bertram (1986/10/31)."Natural history of patients with congestive heart failure: Potential role of converting enzyme inhibitors in improving survival." The American Journal of Medicine 81(4, Supplement 3): 32-35. <http://hdl.handle.net/2027.42/26008> | en_US |
dc.identifier.uri | http://www.sciencedirect.com/science/article/B6TDC-4CHHKM4-7W/2/2b2fe9db8475af3fe2c25eb793e9f417 | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/26008 | |
dc.identifier.uri | http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=2877579&dopt=citation | en_US |
dc.description.abstract | To alter the natural history of congestive heart failure and change the poor prognosis for patients with this condition will require new insights into its pathogenesis as well as the development of strategies to alter the neurohumeral and serum electrolyte abnormalities associated with congestive heart failure, which are often exaggerated by current therapeutic approaches. Although improvement in hemodynamics and exercise tolerance in patients with congestive heart failure remains important, the emphasis of therapeutic goals should be shifted to prevent further cardiac deterioration and to prevent sudden cardiac death. The use of converting enzyme inhibitors holds promise for a beneficial effect on the altered hemodynamic, electrolyte, and neurohumeral abnormalities associated with congestive heart failure. If further prospective randomized trials confirm the beneficial effects of these agents in reducing the mortality rate among patients with congestive heart failure, it is likely that these benefits will have stemmed from their effects on neurohumeral factors and serum electrolyte abnormalities rather than from their effects on hemodynamics. | en_US |
dc.format.extent | 450441 bytes | |
dc.format.extent | 3118 bytes | |
dc.format.mimetype | application/pdf | |
dc.format.mimetype | text/plain | |
dc.language.iso | en_US | |
dc.publisher | Elsevier | en_US |
dc.title | Natural history of patients with congestive heart failure: Potential role of converting enzyme inhibitors in improving survival | en_US |
dc.type | Article | en_US |
dc.rights.robots | IndexNoFollow | en_US |
dc.subject.hlbsecondlevel | Family Medicine and Primary Care | en_US |
dc.subject.hlbtoplevel | Health Sciences | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.contributor.affiliationum | Division of Cardiology, Department of Internal Medicine, University of Michigan Hospitals, Ann Arbor, Michigan, USA | en_US |
dc.identifier.pmid | 2877579 | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/26008/1/0000075.pdf | en_US |
dc.identifier.doi | http://dx.doi.org/10.1016/0002-9343(86)90942-3 | en_US |
dc.identifier.source | The American Journal of Medicine | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.